Correlation of findings on transvaginal sonography with serum CA 125 levels

American Journal of Roentgenology

Volumn 168, Issue 6, 1997, Pages 1587-1590

  Troiano, Robert N ^a   Quedens Case, Gara ^a   Taylor, Kenneth J W ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GYNECOLOGIC CANCER; GYNECOLOGIC DISEASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PELVIC DISEASE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; TRANSVAGINAL ECHOGRAPHY;

EID: 0030990812     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.168.6.9168732     Document Type: Article

References (18)

1. Bast RC Jr, Freeney M, Lazarus H, et al. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Im-est 1981; 68: 1331-1337
2. Bast RC Jr, Klug TL, St. John E, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian carcinoma. N EngUMed 1983; 309: 883-887
3. Jacobs I, Bast RC. The CA 125 tumour-associated antigen: a review of the literature. Hum Reprod 1989; 4: 1-12
4. Bromley B, Goodman II, Benacerraf BR. Comparison between sonographic morphology and Doppler waveform for the diagnosis of ovarian malignancy. Obstet Gynecol 1994; 83: 434-437
5. Koonings PP, Campbell K, Mishell DR, et al. Relative frequency of primary ovarian neoplasms: a ten year review. Obstet Gynecol 1989; 74: 921-926
6. Vasilev SA, Schlaerth JB, Campeau J, et al. Serum CA 125 levels in preoperative evaluation of pelvic masses. Obstet Gynecol 1988; 71: 751-756
7. Weiner Z, Thaler I, Beck D, et al. Differentiating malignant from benign ovarian tumors with transvaginal color flow imaging. Obstet Gynecol 1992; 79: 159-162
8. Hata K, Hata T, Manabe A, et al. A critical evaluation of transvaginal Doppier studies, transvaginal sonography, magnetic resonance imaging, and CA 125 in detecting ovarian cancer. Obstet Gynecol 1992; 80: 922-926
9. Schneider VL, Schneider A, Reed KL, et al. Comparison of Doppler with two-dimensional sonography and CA 125 for prediction of malignancy of pelvic masses. Obstet Gynecol 1993; 81: 983-988
10. Sengoku K, Satoh T, Abe M, et al. Evaluation of transvaginal color Doppler sonography, transvaginal sonography and CA 125 for prediction of ovarian malignancy. IntJ Gynaecol Obstet I994; 46: 39-40
11. Zannetta G, Vergani P, Lissom A. Color Doppler ultrasound in the preoperative assessment of adnexal masses. Acta Obstet Gynecol Scand 1994; 73: 637-641
12. Franchi M, Beretta P, Ghezzi F, et al. Diagnosis of pelvic masses with transabdominal color Doppler, CA 125 and ultrasonography. Acta Obstet Gynecol Scand 1995; 74: 734-739
13. Di-Xia C, Schwartz P, Xinguo L, et al. Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses. Obstet Gynecol 1988; 72: 23-27
14. Predanic M, Vlahos N, Pennisi JA, et al. Color and pulsed Doppler sonography, gray-scale imaging and serum CA 125 in the assessment of adnexal disease. Obstet Gynecol 1996; 88: 283-287
15. Valentin L, Sladkevicius P, Marsal K. Limited contribution of Doppler velocimetry to the differential diagnosis of extrauterine pelvic tumors. Obstet Gynecol 1994; 83: 425-433
16. Wu CC, Lee CN, Chen TM, et al. Incremental angiogenesis assessed by color Doppler ultrasound in the tumorigenesis of ovarian neoplasms. Cancer 1994; 73: 1251-1256
17. Kawai M, Kano T, Kikkawa F, et al. Transvaginal Doppler ultrasound with color flow imaging in the diagnosis of ovarian cancer. Obstet Gynecol 1992; 79: 163-167
18. Salem S, White LM, Lai J. Doppler sonography of adnexal masses: the predictive value of the pulsatility index in benign and malignant disease. AIR 1994; 163: 1147-1150